Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Miguel Ángel Gutiérrez-Monreal, MSc, Luis Villela, MD, Yocanxochitl Perfecto, MSc, Samuel Kettenhofen, Guy Cardineau, PhD, Severiano Baltazar, MD, Job Cortez, MD, Sean-Patrick Scott, PhD

Blood (2010) 116 (21): 2478.

https://doi.org/10.1182/blood.V116.21.2478.2478

Published: 2010

Journal Articles

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Francisco Tripp, MD, Enrique Báez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Oscar Garcés, MD, Gustavo Reyes, MD, Benjamín Batista, MD, Alva Zaragoza, MD, Jorge Vela-Ojeda, MD, Luis Villela, MD

Blood (2007) 110 (11): 4489.

https://doi.org/10.1182/blood.V110.11.4489.4489

Published: 2007

Journal Articles

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Gregorio Ignacio, MD, Francisco Tripp, MD, Petty Rodríguez, MD, Mario Martínez, MD, Concepción Martínez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Alva Zaragoza, MD, Silvia Rivas, MD, Eduardo E. Reynoso, MD

Blood (2007) 110 (11): 4407.

https://doi.org/10.1182/blood.V110.11.4407.4407

Published: 2007

Journal Articles

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Silvia Rivas-Vera, MD, Enrique Baez, MD, Pedro Sobrevilla-Calvo, MD, Severiano Baltazar, MD, Francisco Tripp, MD, Jorge Vela, MD, Oscar Garces, MD, Luis Aguilar, MD, Gregorio Ignacio, MD, Jorge Duque, MD, Petty Rodriguez, MD, Gustavo Reyes, MD

Blood (2005) 106 (11): 2431.

https://doi.org/10.1182/blood.V106.11.2431.2431

Published: 2005

Journal Articles

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Rosa M. Arana, QFB, Pedro Sobrevilla-Calvo, MD, Silvia Rivas-Vera, MD, Enrique Baez, MD, Severiano Baltazar, MD, Jorge Duque, MD, Ignacio Gregorio, MD, Francisco Tripp, MD, Oscar Garces, MD, Luis Aguilar, MD, Luis Flores, MD

Blood (2005) 106 (11): 4493.

https://doi.org/10.1182/blood.V106.11.4493.4493

Published: 2005

Journal Articles

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Jose R. Borbolla Escoboza, MD, Manuel A. Lopez-Hernandez, MD, Marcos E. Garza, MD, Enrique Baez, MD, Elvira Trueba, MD, Roberto Hernandez, MD, Jose E. DeDiego-FloresChapa, MD, Severiano Baltazar, MD, Martha Alvarado, MD, Gerardo Villareal, MD, Mauricio C. Gonzalez-Avante, MD, Rosa E. De Leon, MD, Jose L. Cedillo, MD, Jason A. Penniecook, MD, Yara E. Tovar, MD, Maria I. Leon, Cecilia Ramirez-Assad, MD

Blood (2004) 104 (11): 5015.

https://doi.org/10.1182/blood.V104.11.5015.5015

Published: 2004

Journal Articles

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Blood (2004) 104 (11): 4312.

https://doi.org/10.1182/blood.V104.11.4312.4312

Published: 2004

NARROW

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Email alerts

ASH Publications

American Society of Hematology

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only